The resolution recognizes amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, as a progressive and fatal neurodegenerative condition that severely impacts a person's ability to perform basic functions such as walking, talking, and breathing. It highlights the alarming statistics surrounding ALS, including the frequency of new diagnoses and the average survival time post-diagnosis, which is typically only two to five years. The resolution also notes the increased risk of ALS among military veterans and emphasizes the importance of access to new therapies, medical equipment, and communication technologies for those living with the disease.

In light of these issues, the resolution proclaims May 2026 as ALS Awareness Month in Missouri, aiming to raise public awareness about the challenges faced by individuals with ALS and their families. It calls for support of ALS research, advocacy for increased funding, and improved access to assistive technologies. The resolution acknowledges the significant contributions of the ALS Association in funding research and projects aimed at finding a cure and improving the quality of life for those affected by ALS, urging all Americans to stand in solidarity with those impacted by this relentless disease.